In tumors, including BrCa [1], TG2 is frequently expressed at higher levels than it is in normal tissues and is involved in the maintenance of cancer stem cells, in sensitivity to therapy, in vascularization, and in spreading by metastasis [61]. The gene discussed is TGM2; the disease is cancer.